Thalidomide does not improve survival in small cell lung cancer

Treating patients with thalidomide in combination with chemotherapy for small cell lung (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published July 16 in the Journal of the National Institute.


Read more

Related posts

Leave a Reply